Quest Diagnostics EVP Catherine Doherty sold 1,433 shares of the company’s stock for $293,521.39, reducing her stake by 2.05%. This transaction followed the company’s strong quarterly earnings, where it beat analyst estimates, provided optimistic FY2026 guidance, increased its dividend, and authorized a $1.00 billion share repurchase plan. DGX stock traded down slightly after the news, with a market capitalization of $22.50 billion.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Quest Diagnostics (NYSE:DGX) EVP Sells $293,521.39 in Stock
Quest Diagnostics EVP Catherine Doherty sold 1,433 shares of the company’s stock for $293,521.39, reducing her stake by 2.05%. This transaction followed the company’s strong quarterly earnings, where it beat analyst estimates, provided optimistic FY2026 guidance, increased its dividend, and authorized a $1.00 billion share repurchase plan. DGX stock traded down slightly after the news, with a market capitalization of $22.50 billion.